Brand tirzepatide
Sold by JRNYS · every brand tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$114
| Medication · Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership) | $25 |
|---|---|
| Required membership | $89 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Insurance price (most members with commercial insurance, after deductible; excludes the separate $89-$169/mo membership fee — see membership) “GLP-1s for most members with commercial insurance should be capped at $25 per month after any deductible is met.” | Per month$25 | Charged today$25 |
We earn nothing from this link. JRNYS has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “Subscribers are required to give a notice of at least 7 days prior to their next billing cycle for cancellation of their subscription.” |
| Membership | Required. $89 per month. “Start for $89/month* *Does not include the cost of medication. ... Membership ranges from $89 per month to $169 per month depending on your level of 1-1 coach support. The base price includes your medical visits, daily monitoring, coaching & access to member exclusive content.” |
Not yet checked: pharmacy, states and consult fee.
Recorded from jrnys.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.